
VC Profile: Jeito Capital in final stretch of biotech fund deployment

Rafaèle Tordjman, Jeito Capital
At a time when many big-ticket GPs are buying up specialist life science investors, France-based Jeito Capital is focused on staying an independent investor as it gears up to deploy the remaining third of its EUR 534m debut fund, founder Rafaèle Tordjman tells Unquote.
Latest News
Raise heads for second close for debut impact VC fund
French sponsor seeks to attract state-backed LPs for new strategy targeting ESG-focused startups
Graphite makes value creation and investment team hires
Director appointments include Rutland Partners' Matt Hamilton-Allen, who joins the investment team
Pantheon closes private debt secondary fund on USD 834m
New vehicle exceeded target by more than USD 300m; aims for up to 20% exposure to European debt
Cathay Capital launches EUR 500m health fund
New vehicle will invest at the crossover of health care, life sciences and tech with EUR 5m-50m tickets
Back to Top